Newsletter Signup
Stay up to date on all the latest news from Boston.com
With the Omicron variant spreading quickly around Massachusetts, Gov. Charlie Baker announced last week the opening of five additional high-capacity COVID vaccination sites. Less than a week into the new year, the sites are now open to the public.
Three of the five new sites are located within Boston, two in the city’s Roxbury neighborhood and the other in Fenway Park. Sites in Lynn and Taunton have also opened as part of this initiative.
These sites are in addition to the nearly 1,000 locations where residents could already receive the COVID vaccine.
All five locations are state-sponsored and accept walk-ins, but appointments can also be made at vaxfinder.mass.gov.
The vaccination center at Fenway Park is set up to administer up to 1,300 doses per day, according to a press release from Gov. Baker. This site is also offering first and second doses for individuals 5 and over, and boosters for those eligible.
The sites in Roxbury are located at the Melnea Cass Recreation Complex and the Whittier Street Health Center.
The Roxbury sites are set up to administer 400 and 500 doses daily, respectively. The Melnea Cass vaccination center is offering Pfizer doses and boosters, and the Whittier Street location offers all three types of the COVID vaccine.
The site in Lynn is located at North Shore Community College and will administer up to 400 doses daily of all three types of the COVID vaccine. In Taunton, a COVID vaccine clinic has been set up at 2005 Bay Street, and can handle 400 doses daily of all three COVID vaccine types.
In Massachusetts about 5.1 million people have been fully vaccinated for COVID, with about 2 million receiving a COVID booster shot, according to the Massachusetts Department of Public Health.
For more information on vaccinations and clinic schedules and openings, visit vaxfinder.mass.gov.
Stay up to date on all the latest news from Boston.com
Stay up to date with everything Boston. Receive the latest news and breaking updates, straight from our newsroom to your inbox.
To comment, please create a screen name in your profile
To comment, please verify your email address
Conversation
This discussion has ended. Please join elsewhere on Boston.com